Gunnar Sachs, Magdalena Thole

European Food and Feed Law Review, Volume 15 (2020), Issue 4, Page 327 - 335

The definition of a ‘medicinal product’ is of critical importance for making a distinction between medicinal products and foods and therefore also in terms of the marketability of specific products. Other factors to consider include product characteristics such as potential health risks arising from the use of a product. Contrary to recent German case law, however, this does not mean that products will only be classified as medicinal products if they are determined to have an inherent health risk. A distinction cannot be made between medicinal products and foods on the basis of the potential risks of a product.

Marc Holtorf, Gunnar Sachs

European Food and Feed Law Review, Volume 5 (2010), Issue 3, Page 6

The new European Legislation on Food Additives, Flavourings and Enzymes I. Introduction In 2008, the European Commission fundamentally reformed the pan-European legislation on food additives, flavourings and food enzymes by adopting the so-called “Food Improvement Agents Package” (“FIAP”), including – the Regulation (EC) No 1331/2008 establishing a common authorisation procedure for food additives, enzymes and flavourings1, – the Regulation (EC)